Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 17 · 1 feed behind: Insider filings, 10 days · Every feed →

All 7,309Congress 2,157Executive branch 468Insiders 4,684
AllBuysSells
Filed late
More filters
DemRepInd
HouseSenateExecutive
$15K+$50K+$100K+$250K+$1M+
Clear filters

Insiders · filed late · 4,684 trades

Trades
4,684
Buys 1,074 · Sells 3,610
People
1,192
Stocks
723
Disclosed value
$7.6B
range midpoints · Congress & executive
Filed late
4,684
  1. ▼ SELLJian Irish DirectorMGX Metagenomi Therapeutics, Inc.$4.9Kdisclosed Jun 10 · filed 5 days after the trade · late
  2. ▲ BUYVivo Opportunity Cayman, LLC 10% ownerINM InMed Pharmaceuticals Inc.$1.1Kdisclosed Jun 10 · filed 7 days after the trade · late
  3. ▲ BUYVivo Opportunity, LLC 10% ownerINM InMed Pharmaceuticals Inc.$25.4Kdisclosed Jun 10 · filed 12 days after the trade · late
  4. ▲ BUYVivo Opportunity, LLC 10% ownerINM InMed Pharmaceuticals Inc.$5.3Kdisclosed Jun 10 · filed 20 days after the trade · late
  5. ▼ SELLPeter A Leidel DirectorMETC Ramaco Resources, Inc.$1.1Mdisclosed Jun 10 · filed 85 days after the trade · late
  6. ▼ SELLPeter A Leidel DirectorMETC Ramaco Resources, Inc.$1.1Mdisclosed Jun 10 · filed 75 days after the trade · late
  7. ▲ BUYVivo Opportunity Cayman Fund, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$970disclosed Jun 10 · filed 6 days after the trade · late
  8. ▲ BUYVivo Opportunity Cayman Fund, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$2.3Kdisclosed Jun 10 · filed 9 days after the trade · late
  9. ▲ BUYVivo Opportunity, LLC 10% ownerINM InMed Pharmaceuticals Inc.$23Kdisclosed Jun 10 · filed 9 days after the trade · late
  10. ▼ SELLPeter A Leidel DirectorMETC Ramaco Resources, Inc.$734Kdisclosed Jun 10 · filed 75 days after the trade · late
  11. ▼ SELLPeter A Leidel DirectorMETC Ramaco Resources, Inc.$2.3Mdisclosed Jun 10 · filed 83 days after the trade · late
  12. ▼ SELLPeter A Leidel DirectorMETC Ramaco Resources, Inc.$43.5Kdisclosed Jun 10 · filed 77 days after the trade · late
  13. ▲ BUYVivo Opportunity, LLC 10% ownerINM InMed Pharmaceuticals Inc.$79.6Kdisclosed Jun 10 · filed 21 days after the trade · late
  14. ▲ BUYVivo Opportunity Cayman Fund, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$52.2Kdisclosed Jun 10 · filed 20 days after the trade · late
  15. ▼ SELLPeter A Leidel DirectorMETC Ramaco Resources, Inc.$1.1Mdisclosed Jun 10 · filed 78 days after the trade · late
  16. ▲ BUYVivo Opportunity Cayman Fund, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$2.6Kdisclosed Jun 10 · filed 12 days after the trade · late
  17. ▲ BUYVivo Opportunity Cayman Fund, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$25.4Kdisclosed Jun 10 · filed 12 days after the trade · late
  18. ▼ SELLPeter A Leidel DirectorMETC Ramaco Resources, Inc.$25.8Kdisclosed Jun 10 · filed 76 days after the trade · late
  19. ▲ BUYVivo Opportunity Cayman Fund, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$9.6Kdisclosed Jun 10 · filed 6 days after the trade · late
  20. ▼ SELLPeter A Leidel DirectorMETC Ramaco Resources, Inc.$17.1Kdisclosed Jun 10 · filed 76 days after the trade · late
  21. ▲ BUYMichael E Pegram DirectorCZR Caesars Entertainment, Inc.$107Kdisclosed Jun 10 · filed 1,125 days after the trade · late
  22. ▲ BUYJack Jiajia Huang Chief Executive OfficerCOE 51Talk Online Education Group$1.4Mdisclosed Jun 10 · filed 8 days after the trade · late
  23. ▲ BUYVivo Opportunity Cayman, LLC 10% ownerINM InMed Pharmaceuticals Inc.$31.5Kdisclosed Jun 10 · filed 8 days after the trade · late
  24. ▼ SELLPeter A Leidel DirectorMETC Ramaco Resources, Inc.$893Kdisclosed Jun 10 · filed 79 days after the trade · late
  25. ▲ BUYVivo Opportunity, LLC 10% ownerINM InMed Pharmaceuticals Inc.$11Kdisclosed Jun 10 · filed 7 days after the trade · late